Human iPSC-derived Alzheimer's disease model
A rapidly maturing, physiologically relevant, functional system for investigating the role of the APP London mutation in early-onset Alzheimer's disease (AD). This in vitro disease cell model recapitulates an increased ratio of amyloid beta peptides A